Literature DB >> 9327674

Treatment of primary multiple early gastric cancer: from the viewpoint of clinicopathologic features.

K Takeshita1, M Tani, T Honda, I Saeki, F Kando, N Saito, M Endo.   

Abstract

The treatment of multiple early gastric cancer was investigated through the clinicopathologic assessment of 61 cases of primary multiple early gastric cancer (82 accessory lesions) treated by surgical resection over a 15-year period. These cases accounted for 11.7% of all cases of early gastric cancer resected during the same period. The 61 patients included 48 men (mean age 64 years) and 13 women (61 years). Of the 82 accessory lesions, 41 (50%) were located in the same region as the main lesion. The most frequent combination of macroscopic types of the main lesion and the accessory lesion was depressed type/depressed type (28 cases). The main lesion was of the well differentiated type in 39 (64%) of the 61 cases; the accessory lesion was also well differentiated in 37 of the 39 cases. Of the 82 accessory lesions, 29 (35%) had been overlooked preoperatively; most of them were located in the middle third of the stomach and included 17 depressed and 10 flat lesions, most of which measured no more than 1 cm. Cases of multiple early gastric cancer are characterized by the predominance of male patients of advanced age (> 60 years), a combination of the same macroscopic type of the main and accessory lesions, and well differentiated carcinoma. Lymph node metastasis and vascular invasion are equally or less frequent than in cases of solitary early gastric cancer. The postoperative crude survival rate in patients with multiple gastric cancer is similar to that in those with solitary gastric cancer. Therefore we believe that multiple early gastric cancer does not require extended operative procedures. Endoscopic treatment may be indicated if each lesion fits the criteria for treatment and careful follow-up is ensured.

Entities:  

Mesh:

Year:  1997        PMID: 9327674     DOI: 10.1007/s002689900313

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  8 in total

Review 1.  Function-preserving surgery for gastric cancer.

Authors:  Hitoshi Katai
Journal:  Int J Clin Oncol       Date:  2006-10       Impact factor: 3.402

2.  Diagnosis and clinical implication of collision gastric adenocarcinomas: a case report.

Authors:  Hiromitsu Imataki; Hideo Miyake; Hidemasa Nagai; Yuichiro Yoshioka; Norihiro Yuasa; Junichi Takamizawa; Ayami Kiriyama; Masahiko Fujino
Journal:  Surg Case Rep       Date:  2022-10-07

3.  Can we resect EGC with Signet ring cells in Europe?

Authors:  Fabrice Caillol; Erwan Bories; Jerôme Guiramand; Christian Pesenti; Florat Poizat; Geneviève Monges; Marc Giovannini
Journal:  J Gastrointest Cancer       Date:  2013-12

4.  Subtotal gastrectomy as treatment for distal multifocal early gastric cancer.

Authors:  Paolo Morgagni; Caterina Marfisi; Andrea Gardini; Daniele Marrelli; Luca Saragoni; Franco Roviello; Giovanni Vittimberga; Domenico Garcea
Journal:  J Gastrointest Surg       Date:  2009-08-12       Impact factor: 3.452

Review 5.  Early gastric cancer: concepts, diagnosis, and management.

Authors:  Hitoshi Katai; Takeshi Sano
Journal:  Int J Clin Oncol       Date:  2005-12       Impact factor: 3.850

6.  Multiple Primary Malignancies in Patients with Multiple Early Gastric Cancer.

Authors:  Dae Hoon Kim; Su Mi Kim; Min Gew Choi; Tae Sung Sohn; Jae Moon Bae; Sung Kim
Journal:  J Gastric Cancer       Date:  2017-06-17       Impact factor: 3.720

7.  Clinicopathological features and risk factors analysis of lymph node metastasis and long-term prognosis in patients with synchronous multiple gastric cancer.

Authors:  Liang Chen; Chao Yue; Gang Li; Xuezhi Ming; Rongmin Gu; Xu Wen; Bin Zhou; Rui Peng; Wei Wei; Huanqiu Chen
Journal:  World J Surg Oncol       Date:  2021-01-21       Impact factor: 2.754

8.  High incidence of other primary malignancies in patients with synchronous multiple gastric cancers "a multi-center retrospective cohort study".

Authors:  Daisuke Takeuchi; Naohiko Koide; Akira Suzuki; Fumiaki Shimizu; Yoshinori Koyama; Takehito Ehara; Yuta Yamamoto; Makoto Koyama; Satoshi Nakamura; Masato Kitazawa; Yusuke Miyagawa; Shinichi Miyagawa
Journal:  Oncotarget       Date:  2018-04-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.